The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts

BACKGROUND: One of the most important biological characteristics of Glioblastoma multiforme (GBM) is high vascular density. Vadimezan (ASA404, DMXAA) belongs to the class of small molecule vascular disrupting agents (VDA) that cause disruption of established tumor vessels and subsequent tumor hemorr...

詳細記述

保存先:
書誌詳細
主要な著者: Milanović, Dušan, Braun, Friederike, Weber, Wolfgang, Grosu, Anca Ligia, Behe, Martin, Niedermann, Gabriele
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2012
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3476988/
https://ncbi.nlm.nih.gov/pubmed/22695475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-242
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料